Mikoseptin® (Mykoseptin®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceUndecylenic acid + Zinc undecylenateUndecylenic acid + Zinc undecylenate
Similar drugsTo uncover
  • Mikoseptin®
    ointment externally 
    SANOFI RUSSIA, CJSC    
    • Dosage form: & nbspointment for external use
    Composition:

    Each tube (30 g of ointment) contains:

    active substances: undecylenic acid 1.500 g, zinc undecylenate 6,000 g;

    >Excipients: stearic acid - 0.390 g white beeswax - 0.690 g, solid paraffin (melting point 64-68 ° C) - 1.500 g, -1.050 g solid paraffin, paraffin zhidkiy- 10,110 g methyl parahydroxybenzoate - 0.060 g macrogol oleate - 1,200 g , distilled monoglycerides - 0,990 g, soft white paraffin - 4,110 g, purified water - 2.400 g

    Description:From almost white to off-white with pale yellowish tint cream with a characteristic odor and a fine fat grains.
    Pharmacotherapeutic group:Antifungal agent
    ATX: & nbsp

    D.01.A.E.54   Undecylenic acid in combination with other drugs

    Pharmacodynamics:Undecylenic acid and its salts have a pronounced fungistatic action against dermatophytes genus Trichophyton, Epidermophyton, Microsporum. Zinc, part of the drug, astringent action, thus reducing manifestations of symptoms of irritation of the skin, promoting more rapid healing.
    Indications:Treatment and prevention of fungal diseases of the skin caused by sensitive to the preparation of fungi (dermatophytes).
    Contraindications:Hypersensitivity to undecylenic acid and its derivatives, parabens, to other components of the drug; children's age (up to 2 years).
    Pregnancy and lactation:Before using the drug during pregnancy and during lactation, it is necessary to consult a doctor, as during pregnancy and during lactation, the drug can be used only if there are strict indications that the doctor should establish if the intended benefit to the mother exceeds the potential risk for the fetus.
    Dosing and Administration:

    For external use.

    Apply on a clean, dry surface of the affected skin 2 times a day. Duration of treatment 4-6 weeks. After the disappearance of clinical manifestations of the disease, to prevent recurrence, it is recommended to apply ointment once a day for a week and then, every other day or twice a week for one month, a reduction in the course of treatment increases the risk of recurrence of the disease.

    Side effects:

    Possible reactions of hypersensitivity to the components, the drug in the form of redness, itching of the skin, edema; burning sensations, skin rashes.

    If signs of hypersensitivity occur, the drug should be discontinued and reported to the doctor.

    Overdose:Cases of overdose are not described. If the drug is taken orally, nausea and vomiting may occur. It is necessary to rinse the stomach and consult a doctor, if necessary, perform symptomatic treatment.
    Interaction:Data on the interaction of the drug MICOSEPTIN® with other drugs have not been obtained. The possibility of simultaneous use of other medicines for external use is determined by the doctor.
    Special instructions:The drug MICOSEPTIN® can not be applied to the open wound surface, the damaged surface of the skin, periorbital zone, avoid getting the ointment in the eyes.
    Form release / dosage:Ointment for external use.
    Packaging:30 g of ointment in an aluminum tube. Each tube is placed in a cardboard box together with instructions for use.
    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children!

    Shelf life:

    3 years.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:П N012407 / 01
    Date of registration:20.10.2011 / 15.01.2018
    Expiration Date:Unlimited
    The owner of the registration certificate:SANOFI RUSSIA, CJSCSANOFI RUSSIA, CJSC
    Manufacturer: & nbsp
    ZENTIVA, k.s. Czech Republic
    Representation: & nbspSanofi Russia, JSCSanofi Russia, JSCRussia
    Information update date: & nbsp07.06.2018
    Illustrated instructions
      Instructions
      Up